Multiple outlets report a health warning in the UK following serious harm associated with an unapproved weight-loss drug referred to as “Reta.” One patient is reported to have died after taking the product, and other people are said to have suffered serious injuries or side effects. The reports describe the drug using informal language and characterize it as a high-risk, non-authorized weight-loss injection, but they do not indicate it has regulatory approval.
According to the available summaries, at least dozens of additional individuals are reported to have experienced significant adverse outcomes after taking the drug, including 76 people who are described as having serious injuries. The coverage emphasizes that the product is unapproved and frames the issue as urgent from a public health perspective.
The reports focus on the alleged link between the drug and the harm experienced, while details such as the clinical nature of the injuries, how many cases are confirmed, the dates involved, and any official regulatory or police actions are not provided in the supplied text.
